• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers.

作者信息

Neuhausen Susan, Dunning Alison, Steele Linda, Yakumo Kazuko, Hoffman Michael, Szabo Csilla, Tee Louise, Baines Caroline, Pharoah Paul, Goldgar David, Easton Doug

机构信息

Division of Epidemiology, Department of Medicine, University of California, Irvine, CA, USA.

出版信息

Int J Cancer. 2004 Jan 20;108(3):477-8. doi: 10.1002/ijc.11385.

DOI:10.1002/ijc.11385
PMID:14648718
Abstract
摘要

相似文献

1
Role of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancers.CHEK2*1100delC在未经选择的非BRCA1/2男性乳腺癌系列中的作用。
Int J Cancer. 2004 Jan 20;108(3):477-8. doi: 10.1002/ijc.11385.
2
CHEK2*1100delC and male breast cancer risk in Israel.以色列CHEK2*1100delC与男性乳腺癌风险
Int J Cancer. 2004 Jan 20;108(3):479-80. doi: 10.1002/ijc.11603.
3
CHEK2 1100delC is not a risk factor for male breast cancer population.CHEK2基因1100delC不是男性乳腺癌人群的风险因素。
Int J Cancer. 2004 Jan 20;108(3):475-6. doi: 10.1002/ijc.11384.
4
BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases.在意大利男性乳腺癌病例中，BRCA1/BRCA2重排和CHEK2常见突变并不常见。
Breast Cancer Res Treat. 2008 Jul;110(1):161-7. doi: 10.1007/s10549-007-9689-2. Epub 2007 Jul 28.
5
CHEK2:1100delC and female breast cancer in the United States.CHEK2基因1100delC与美国女性乳腺癌
Int J Cancer. 2004 Nov 10;112(3):541-3. doi: 10.1002/ijc.20439.
6
CHEK2 1100delC and male breast cancer in the Netherlands.荷兰的 CHEK2 1100delC 与男性乳腺癌
Breast Cancer Res Treat. 2009 Jul;116(2):397-400. doi: 10.1007/s10549-008-0162-7. Epub 2008 Aug 31.
7
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.乳腺癌高危家族中BRCA1、BRCA2、CHEK2和TP53的突变谱。
JAMA. 2006 Mar 22;295(12):1379-88. doi: 10.1001/jama.295.12.1379.
8
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.CHEK2*1100delC变异体在非BRCA1/BRCA2多病例家族中作为乳腺癌风险修饰因子发挥作用。
Cancer Res. 2003 Dec 1;63(23):8153-7.
9
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.多基因检测队列中的男性乳腺癌：见解与意外结果
Breast Cancer Res Treat. 2017 Feb;161(3):575-586. doi: 10.1007/s10549-016-4085-4. Epub 2016 Dec 22.
10
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.在 BRCA1 或 BRCA2 基因无突变的个体中，CHEK2(*)1100delC 导致的乳腺癌低外显率易感性。
Nat Genet. 2002 May;31(1):55-9. doi: 10.1038/ng879. Epub 2002 Apr 22.

引用本文的文献

1
Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell Carcinoma.透明细胞和非透明细胞肾细胞癌种系罕见变异的综合分析
Eur Urol Open Sci. 2024 Mar 8;62:107-122. doi: 10.1016/j.euros.2024.02.006. eCollection 2024 Apr.
2
Gender-Specific Genetic Predisposition to Breast Cancer: Genes and Beyond.乳腺癌的性别特异性遗传易感性：基因及其他因素
Cancers (Basel). 2024 Jan 30;16(3):579. doi: 10.3390/cancers16030579.
3
Male Breast Cancer: An Updated Review of Epidemiology, Clinicopathology, and Treatment.男性乳腺癌：流行病学、临床病理学及治疗的最新综述
J Oncol. 2022 May 24;2022:1734049. doi: 10.1155/2022/1734049. eCollection 2022.
4
Genetic predisposition to male breast cancer in Poland.波兰男性乳腺癌的遗传易感性。
BMC Cancer. 2021 Aug 30;21(1):975. doi: 10.1186/s12885-021-08718-3.
5
Genetic Landscape of Male Breast Cancer.男性乳腺癌的基因图谱
Cancers (Basel). 2021 Jul 15;13(14):3535. doi: 10.3390/cancers13143535.
6
Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling.非BRCA相关男性乳腺癌患者的家族乳腺癌病史：对癌症风险咨询的意义
Breast Cancer Res Treat. 2021 Jan;185(1):195-204. doi: 10.1007/s10549-020-05922-w. Epub 2020 Sep 11.
7
Association Between CHEK2*1100delC and Breast Cancer: A Systematic Review and Meta-Analysis.CHEK2*1100delC 与乳腺癌的关联：系统评价和荟萃分析。
Mol Diagn Ther. 2018 Aug;22(4):397-407. doi: 10.1007/s40291-018-0344-x.
8
CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.CHEK2 c.1100delC 突变与芬兰患者群体中男性乳腺癌风险增加相关。
BMC Cancer. 2017 Sep 5;17(1):620. doi: 10.1186/s12885-017-3631-8.
9
Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.多基因检测队列中的男性乳腺癌：见解与意外结果
Breast Cancer Res Treat. 2017 Feb;161(3):575-586. doi: 10.1007/s10549-016-4085-4. Epub 2016 Dec 22.
10
The Epidemiology of Male Breast Cancer.男性乳腺癌的流行病学
Curr Oncol Rep. 2016 Jan;18(1):1. doi: 10.1007/s11912-015-0487-4.